What is the story about?
New
Delhi, Jul 30 (PTI) Ajanta Pharma Ltd on Thursday reported a 31 per cent rise in profit after tax to Rs 334 crore for the first quarter ended June 30.
The company had posted a profit after tax (PAT) of Rs 255 crore in the corresponding period of the last fiscal, Ajanta Pharma said in a regulatory filing.
Its revenue from operations grew 25 per cent to Rs 1,626 crore in the first quarter against Rs 1,303 crore in the year-ago period, it added.
Branded generics revenue in India increased 24 per cent to Rs 509 crore from Rs 409 crore a year ago, the company said.
US generic revenue jumped 57 per cent to Rs 487 crore compared to Rs 310 crore in the year-ago period, it noted. PTI RKL BAL BAL BAL
/images/ppid_59c68470-image-178523005869551062.webp)
/images/ppid_59c68470-image-178531502913572851.webp)
/images/ppid_59c68470-image-17851476299495412.webp)
/images/ppid_59c68470-image-17854050403846156.webp)
/images/ppid_59c68470-image-178533255983978474.webp)


/images/ppid_59c68470-image-178540252327625312.webp)
/images/ppid_59c68470-image-17852351931261499.webp)
/images/ppid_59c68470-image-178520252950073233.webp)

/images/ppid_59c68470-image-178522514908568865.webp)